Study of Bemnifosbuvir on Cardiac Repolarization in Healthy Subjects
Clinical trial NCT05905484 · COMPLETED
Trial details
- NCT number
- NCT05905484
- Sponsor
- Atea Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-25
- Primary completion
- 2023-05-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.